TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
$1,046,094
| Recipient | UNIVERSITY OF OKLAHOMA UEI GY8NMUZQXVS7 |
|---|---|
| Award ID | 75N91022F00002 |
| Award amount | $1,046,094 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Health and Human Services — National Institutes of Health |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN12 |
| Start date | Aug 5, 2022 |
| End date | Aug 4, 2024 |
| Place of performance | OKLAHOMA CITY, OK |
| Record updated | Aug 2, 2022 |
View the official award record
More awards won by UNIVERSITY OF OKLAHOMA
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Department of Health and Human Services · $149,995,000 · Jan 25, 2024
UNMANNED AIRCRAFT SYSTEMS (UAS) CENTER OF EXCELLENCE (COE) COMPANION IDIQ CONTRACTS
Department of Transportation · $98,321,404 · Sep 4, 2025
MAINTAINING SAFETY AND EFFICIENCY OF THE NAS WITH THE INTEGRATION OF COUNTER UAS TECHNOLOGIES RESEARCH PROGRAM
Department of Transportation · $10,000,000 · Jul 1, 2026
NWS/OBS: RESEARCH AND DEVELOPMENT SERVICES IN SUPPORT OF RADAR NEXT PROGRAM
Department of Commerce · $10,000,000 · Feb 20, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids